Arsenic species, AS3MT amount, and AS3MT gen expression in different brain regions of mouse exposed to arsenite

Environmental Research

Volumn 110, Issue 5, 2010, Pages 428-434

  Sánchez Peña, Luz C ^a   Petrosyan, Pavel ^b   Morales, Mariana ^b   González, Nydia B ^b   Gutiérrez Ospina, Gabriel ^b   Del Razo, Luz M ^a   Gonsebatt, Maria E ^b  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Arsenic species accumulation; AS3MT expression; Mouse brain regions

Indexed keywords

ARSENIC METHYLTRANSFERASE; ARSENITE SODIUM; MESSENGER RNA; METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ARSENIC; ARSENITE; BEHAVIORAL RESPONSE; BIOACCUMULATION; BRAIN; ENDOCRINE DISRUPTOR; GENE EXPRESSION; METABOLISM; MODELING; POLLUTION EXPOSURE; RODENT; TOXICITY;

ANIMAL EXPERIMENT; ARTICLE; BIOACCUMULATION; BRAIN CORTEX; BRAIN METABOLISM; CEREBELLUM; CONTROLLED STUDY; CORPUS STRIATUM; ENVIRONMENTAL EXPOSURE; GENE EXPRESSION; HIPPOCAMPUS; HYPOPHYSIS; HYPOTHALAMUS; MALE; MEDULLA OBLONGATA; MESENCEPHALON; METABOLITE; METHYLATION; MOUSE; NONHUMAN; PONS; PRIORITY JOURNAL; PROTEIN EXPRESSION; THALAMUS;

ANIMALS; ARSENIC; ARSENITES; BRAIN; GENE EXPRESSION; MALE; METHYLTRANSFERASES; MICE; SODIUM COMPOUNDS;

MUS; RODENTIA;

EID: 77953622000     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2010.01.007     Document Type: Article

References (41)

1. Agency for Toxic Substances and Disease Registry (ATSDR), 2005. Toxicological Profile For Arsenic, 2000, pp. 115-116.
2. Axelrod J., Tomchick R. Enzymatic O-methylation of epinephrine and other catechols. J. Biol. Chem. 1958, 233:702-705.
3. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
4. Calderon J., Navarro M.E., Jimenez-Capdeville M.E., Santos-Diaz M.A., Golden A., Rodriguez-Leyva I., Borja-Aburto V., Diaz-Barriga F. Exposure to arsenic and lead and neuropsychological development in Mexican children. Environ. Res. 2001, 85:69-76.
5. Campbell N.R.C., Dunnette J.H., Mwaluko G., Van Loon J., Weinshilboum R.M. Platelet phenol sulfotransferase and erythrocyte catechol-O-methyltransferase activities: correlation with methyldopa metabolism in man. Clin. Pharmacol. Ther. 1984, 35:55-63.
6. Delgado J.M., Dufour L., Grimaldo J.I., Carrizales L., Rodríguez V.M., Jiménez-Capdeville M.E. Effects of arsenite on central monoamines and plasmatic levels of adrenocorticotropic hormone (ACTH) in mice. Toxicol. Lett. 2000, 117:61-67.
7. Drobna Z., Waters S.B., Devesa V., Harmon A.W., Thomas D.J., Styblo M. Metabolism and toxicity of arsenic in human urothelial cells expressing rat arsenic (+3 oxidation state)-methyltransferase. Toxicol. Appl. Pharmacol. 2005, 207:147-159.
8. Drobna Z., Xing W., Thomas D.J., Styblo M. shRNA silencing of AS3MT expression minimizes arsenic methylation capacity of HepG2 cells. Chem. Res. Toxicol. 2006, 19:894-898.
9. Glowinski J., Iversen L. Regional studies of catecholamines in the rat brain. 3. Subcellular distribution of endogenous and exogenous catecholamines in various brain regions. Biochem. Pharmacol. 1966, 15:977-987.
10. Guldberg H.C., Marsden C.A. Catechol-O-methyltransferase: pharmacological aspects and physiological role. Pharmacol. Rev. 1975, 27:135-206.
11. Hata I., Shigematsu Y., Ohshima Y., Tsukahara H., Fujisawa K., Hiraoka M., Nakamura N., Masutani H., Yodoi J., Kotsuji F., Sudo M., Mayumi M. Involvement of thioredoxin in the regulation of growth hormone secretion in rat pituitary cell cultures. Am. J. Physiol. Endocrinol. Metab. 2001, 281:E269-E274.
12. Hernández-Zavala A., Matoušek T., Drobná Z., Paul D.S., Walton F., Adair B.M., Jiří D., Thomas D.J., Stýblo M. Speciation analysis of arsenic in biological matrices by automated hydride generation-cryotrapping-atomic absorption spectrometry with multiple microflame quartz tube atomizer (multiatomizer). J. Anal. At. Spectrom. 2008, 23:342-351.
13. Hughes M.F., Kenynon E.M., Edwards B.C., Mitchell C.T., Del Razo L.M., Thomas D.J. Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate. Toxicol. Appl. Pharmacol. 2003, 191:202-210.
14. Itoh T., Zhang Y.F., Murai S., Saito H., Nagahama H., Miyate H., Saito Y., Abe E. The effects of arsenic trioxide on brain monoamine metabolism and locomotor activity of mice. Toxicol. Lett. 1990, 54:345-353.
15. Jana K., Jana S., Samanta.P.K. Effects of chronic exposure to sodium arsenite on hypothalamo-pituitary-testicular activities in adult rats: possible an estrogenic mode of action. Reprod. Biol. Endocrinol. 2006, 4:9.
16. Kang Y., Viswanath V., Jha N., Qiao X., Mo J., Andersen J. Brain gamma-glutamyl cysteine synthetase (GCS) mRNA expression patters correlate with regional-specific enzyme activities and glutathione levels. J. Neurosci. Res. 1999, 58:436-441.
17. Kobayashi Y., Hayakawa T., Hirano S. Expression and activity of arsenic methyltransferase Cyt19 in rat tissues. Environ. Toxicol. Pharmacol. 2007, 23:115-120.
18. Krüger K., Repges H., Hippler J., Hartmann L.M., Hirner A.V., Straub H., Binding N., Mußhoff U. Effects of dimethylarsinic and dimethylarsinous acid on evoked synaptic potentials in hippocampal slices of young and adult rats. Toxicol. Appl. Pharmacol. 2007, 225:40-46.
19. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
20. Lianfang W., Jianzhong H. Chronic arsenism from drinking water in some areas of Xinjiang, China. Arsenic in the Environment: Part II: Human Health and Ecosystem Effects 1994, 159-172. John Wiley and Sons, Inc., New York. J.O. Nriagu (Ed.).
21. Lillig C.H., Holmgren A. Thioredoxin and related molecules-from biology to health and disease. Antioxid. Redox Signal 2007, 9:25-47.
22. Limón-Pacheco J.H., Hernández N., Fanjul-Moles M.L., Gonsebatt M.E. Glutathione depletion activates MAPK pathways that display organ-specific responses and brain protection in mice. Free Radical Biol. Med. 2007, 43:1335-1347.
23. Limón-Pacheco J.H., Gonsebatt M.E. The role of antioxidants and antioxidant-related enzymes in the protective response to environmentally-induce oxidative stress. Mutat. Res. Gen. Toxicol. Environ. Mutagenesis 2009, 674:137-147.
24. Martinez E.J., Kolb B.L., Bell A., Savage D.D., Allan A.M. Moderate perinatal arsenic exposure alters neuroendocrine markers associated with depression and increases depressive-like behaviors in adult mouse offspring. Neurotoxicology 2008, 29:647-655.
25. Matoušek T., Hernández-Zavala A., Svoboda M., Langrová L., Adair B.M., Drobná Z., Thomas D.J., Stýblo M., Dědina J. Oxidation state specific generation of arsines from methylated arsenicals based on l-cysteine treatment in buffered media for speciation analysis by hydride generation-automated cryotrapping-gas chromatography-atomic absorption spectrometry with the multiatomizer. Spectrochim. Acta B At. Spectrosc. 2008, 63:396-406.
26. Mejía J.J., Díaz-Barriga F., Calderón J., Ríos C., Jiménez-Capdeville M.E. Effects of lead-arsenic combined exposure on central monoaminergic systems. Neurotoxicol. Teratol. 1997, 19:489-497.
27. Nagaraja T.N., Desiraju T. Effects on operant learning and brain acetylcholine esterase activity in rats following chronic inorganic arsenic intake. Hum. Exp. Toxicol. 1994, 13:353-356.
28. Patenaudea A., Murthyb M.R.V., Mirault M.E. Emerging roles of thioredoxin cycle enzymes in the central nervous system. Cell. Mol. Life Sci. 2005, 62:1063-1080.
29. Rao M.V., Avani G. Arsenic induced free radical toxicity in brain of mice. Indian J. Exp. Biol. 2004, 42:495-498.
30. Reilly D.K., Rivera-Calimlim L., Van Dyke D. Catechol-O-methyltransferase activity: a determinant of levodopa response. Clin. Pharmacol. Ther. 1980, 28:278-286.
31. Rodríguez V.M., Carrizales L., Jiménez-Capdeville M.E., Dufour L., Giordano M. The effects of sodium arsenite exposure on behavioral parameters in the rat. Brain Res. Bull. 2001, 55:301-308.
32. Rodríguez V.M., Jiménez-Capdeville M.E., Giordano M. The effects of arsenic exposure on the nervous system. Toxicol. Lett. 2003, 145:1-18.
33. Rodríguez V.M., Del Razo L.M., Limón-Pacheco J.H., Giordano M., Sánchez-Peña L.C., Uribe-Querol E., Gutiérrez-Ospina G., Gonsebatt M.E. Glutathione reductase inhibition and methylated arsenic distribution in CD1 mice brain and liver. Toxicol. Sci. 2005, 84:157-166.
34. Rosado J.L., Ronquillo D., Kordas K., Rojas O., Alatorre J., Lopez P., Garcia-Vargas G., Caamaño M.C., Cebrián M.E., Stoltzfus R.J. Arsenic exposure and cognitive performance in Mexican schoolchildren. Environ. Health Perspect. 2007, 115:1371-1375.
35. Shila S., Subathra M., Devi M.A., Panneerselvam C. Arsenic intoxication-induced reduction of glutathione level and of the activity of related enzymes in rat brain regions: reversal by DL-a-lipoic acid. Arch. Toxicol. 2005, 79:140-146.
36. Shila S., Kokilavani V., Subathra M., Panneerselvam C. Brain regional responses in antioxidant system to alfa-lipoic acid in arsenic intoxicated rat. Toxicology 2005, 210:25-36.
37. Soerensen, J., Jakupoglu, C., Beck, H., Förster, H., Schmidt, J., Schmahl, W., Schweizer, U., Conrad, M., Brielmeier, M., 2008. The role of thioredoxin reductases in brain development. PLoS ONE 3, e1813. doi: 10.1371/journal.pone.0001813.
38. Styblo M., Drobna Z., Jaspers I., Lin S., Thomas D.J. The role of biomethylation in toxicity and carcinogenicity of arsenic. A research update. Environ. Health Perspect. 2002, 110(Suppl. 5):767-771.
39. Thomas D.J. Molecular processes in cellular arsenic metabolism. Toxicol. Appl. Pharmacol. 2007, 222:365-373.
40. Tsai S.Y., Chou H.Y., The H.W., Chen C.M., Chen C.J. The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology 2003, 24:747-753.
41. Wasserman G.A., Liu X., Parvez F., Ahsan H., Factor-Litvak P., Van Geen A., Slavkovich V., LoIacono N.J., Cheng Z., Hussain I., Momotaj H., Graziano J.H. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ. Health Perspect. 2004, 112:1329-1333.